We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

Back to rankings

29 hedge funds and large institutions have $32.3M invested in Fibrocell Science Inc. in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more capital invested

Capital invested by funds: $16.1M → $32.3M (+$16.1M)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

4% more funds holding

Funds holding: 28 → 29 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
8
Closed
4
Calls
$40K
Puts
–
Net Calls
+$40K
Net Calls Change
+$40K

Top Buyers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
+$120K
2
PPA
Parametric Portfolio Associates
Washington
+$86.4K
3
Morgan Stanley
Morgan Stanley
New York
+$70.2K
4
VKH
Virtu KCG Holdings
New York
+$53.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$52.8K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$118K
2
BlackRock
BlackRock
New York
-$67.1K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$64K
4
Goldman Sachs
Goldman Sachs
New York
-$48K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$45.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$22.2M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$3.41M -$45.9K -3,719 -2%
MP
3
MSD Partners
New York
$2.78M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.39M -$118K -9,538 -12%
Renaissance Technologies
5
Renaissance Technologies
New York
$434K +$52.8K +4,280 +25%
Cambridge Investment Research Advisors
6
Cambridge Investment Research Advisors
Iowa
$272K – – –
Creative Planning
7
Creative Planning
Kansas
$245K +$120K +9,751 +395%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$235K -$4.23K -343 -3%
PPA
9
Parametric Portfolio Associates
Washington
$194K +$86.4K +7,000 +264%
BlackRock
10
BlackRock
New York
$171K -$67.1K -5,438 -39%
Morgan Stanley
11
Morgan Stanley
New York
$147K +$70.2K +5,686 +343%
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$146K – – –
SCA
13
STALEY CAPITAL ADVISERS
Pennsylvania
$132K – – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
$127K +$12 +1 +0%
VKH
15
Virtu KCG Holdings
New York
$87K +$53.2K +4,314 New
CCA
16
Conservest Capital Advisors
Pennsylvania
$67K – – –
FSA
17
Franklin Street Advisors
North Carolina
$67K – – –
Northern Trust
18
Northern Trust
Illinois
$64K – – –
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$53K -$814 -66 -2%
UBS Group
20
UBS Group
Switzerland
$9K +$5.44K +441 New
Wells Fargo
21
Wells Fargo
California
$8K +$592 +48 +14%
Simplex Trading
22
Simplex Trading
Illinois
$6K +$3.83K +310 New
TRCT
23
Tower Research Capital (TRC)
New York
$3K -$3.25K -263 -67%
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K -$123 -10 -8%
TWA
25
TCI Wealth Advisors
Arizona
$2K +$580 +47 +142%
1
2

FCSC Hedge Fund Activity: Q2 2017 in Review

29 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q2 2017, worth a combined $32.3M — up 100% from $16.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new FCSC positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Creative Planning, adding an estimated $120K. The largest seller was Vanguard Group, cutting an estimated $118K.

  • 29 institutional investors held Fibrocell Science Inc. (FCSC) as of Q2 2017, up from 28 in Q1 2017.
  • Funds reported $32.3M of Fibrocell Science Inc. stock for Q2 2017, up 100% quarter-over-quarter.
  • 5 funds opened new Fibrocell Science Inc. positions in Q2 2017 and 4 closed out, a net change of +1 holder.
  • The largest Fibrocell Science Inc. buyer in Q2 2017 was Creative Planning, an estimated $120K added.
  • The largest Fibrocell Science Inc. seller in Q2 2017 was Vanguard Group, an estimated $118K sold.

Based on aggregated 13F filings for Q2 2017.